MKEAMilton Keynes Energy Agency (UK)
MKEAMatthews Kapetas Ehrlich Architects (Australia)
References in periodicals archive ?
Mauna Kea Technologies (Euronext: MKEA, FR0010609263), the French inventor of Cellvizio, the multidisciplinary confocal laser endomicroscopy platform, has obtained approval from China's Food and Drug Administration for its latest version of Cellvizio 100s and for associated miniprobes dedicated to applications in pancreatic diseases (needle-based Confocal Laser Endomicroscopy, nCLE) and urology, the company said on Tuesday.
Each classroom now has in-focus projectors and I-Pads were issued to all kindergarten teachers as part of the new MKEA assessment program mandated by the state.
Recently published study results show that needle-based confocal endomicroscopy procedures safely performed with Mauna Kea Technologies' (Euronext: MKEA, FR0010609263) Cellvizio multidisciplinary confocal laser endomicroscopy platform were successfully able to differentiate mucinous from non-mucinous pancreatic cysts with a high degree of accuracy, the company said on Wednesday.